全文获取类型
收费全文 | 1495篇 |
免费 | 176篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 47篇 |
妇产科学 | 25篇 |
基础医学 | 195篇 |
口腔科学 | 32篇 |
临床医学 | 278篇 |
内科学 | 290篇 |
皮肤病学 | 47篇 |
神经病学 | 105篇 |
特种医学 | 143篇 |
外科学 | 169篇 |
综合类 | 25篇 |
预防医学 | 126篇 |
眼科学 | 17篇 |
药学 | 77篇 |
肿瘤学 | 100篇 |
出版年
2023年 | 14篇 |
2022年 | 13篇 |
2021年 | 28篇 |
2020年 | 16篇 |
2019年 | 45篇 |
2018年 | 43篇 |
2017年 | 42篇 |
2016年 | 48篇 |
2015年 | 35篇 |
2014年 | 64篇 |
2013年 | 53篇 |
2012年 | 40篇 |
2011年 | 61篇 |
2010年 | 60篇 |
2009年 | 64篇 |
2008年 | 56篇 |
2007年 | 48篇 |
2006年 | 45篇 |
2005年 | 58篇 |
2004年 | 39篇 |
2003年 | 39篇 |
2002年 | 38篇 |
2001年 | 37篇 |
2000年 | 33篇 |
1999年 | 43篇 |
1998年 | 43篇 |
1997年 | 45篇 |
1996年 | 44篇 |
1995年 | 33篇 |
1994年 | 32篇 |
1993年 | 36篇 |
1992年 | 30篇 |
1991年 | 26篇 |
1990年 | 21篇 |
1989年 | 35篇 |
1988年 | 19篇 |
1987年 | 33篇 |
1986年 | 24篇 |
1985年 | 13篇 |
1984年 | 16篇 |
1983年 | 13篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1976年 | 10篇 |
1975年 | 9篇 |
1974年 | 11篇 |
1973年 | 13篇 |
排序方式: 共有1680条查询结果,搜索用时 15 毫秒
31.
R. James Stubbs Cristiana Duarte Ruairi O'Driscoll Jake Turicchi Dominika Kwasnicka Falko F. Sniehotta Marta M. Marques Graham Horgan Sofus Larsen Antnio Palmeira Inês Santos Pedro J. Teixeira Jason Halford Berit Lilienthal Heitmann 《Obesity facts》2021,14(2):246
There is substantial evidence documenting the effects of behavioural interventions on weight loss (WL). However, behavioural approaches to initial WL are followed by some degree of longer-term weight regain, and large trials focusing on evidence-based approaches to weight loss maintenance (WLM) have generally only demonstrated small beneficial effects. The current state-of-the-art in behavioural interventions for WL and WLM raises questions of (i) how we define the relationship between WL and WLM, (ii) how energy balance (EB) systems respond to WL and influence behaviours that primarily drive weight regain, (iii) how intervention content, mode of delivery and intensity should be targeted to keep weight off, (iv) which mechanisms of action in complex interventions may prevent weight regain and (v) how to design studies and interventions to maximise effective longer-term weight management. In considering these issues a writing team within the NoHoW Consortium was convened to elaborate a position statement, and behaviour change and obesity experts were invited to discuss these positions and to refine them. At present the evidence suggests that developing the skills to self-manage EB behaviours leads to more effective WLM. However, the effects of behaviour change interventions for WL and WLM are still relatively modest and our understanding of the factors that disrupt and undermine self-management of eating and physical activity is limited. These factors include physiological resistance to weight loss, gradual compensatory changes in eating and physical activity and reactive processes related to stress, emotions, rewards and desires that meet psychological needs. Better matching of evidence-based intervention content to quantitatively tracked EB behaviours and the specific needs of individuals may improve outcomes. Improving objective longitudinal tracking of energy intake and energy expenditure over time would provide a quantitative framework in which to understand the dynamics of behaviour change, mechanisms of action of behaviour change interventions and user engagement with intervention components to potentially improve weight management intervention design and evaluation. 相似文献
32.
33.
Summary The BBZ/Wor rat is a model of obesity and autoimmune diabetes mellitus developed by crossing the BB/Wor and Zucker rats. We
studied circulating glucose and insulin levels, islet morphology and lymphocyte subsets in lean and obese BBZ/Wor rats before
and after the onset of diabetes, and studied the clinical course of diabetes in animals after interruption of exogenous insulin
therapy. Lean BBZ/Wor rats developed insulin-dependent diabetes and died in ketoacidosis within 1 week after cessation of
insulin injections. Diabetes also developed in obese rats, but these animals were not insulin-dependent and survived for months
without insulin therapy. The islets of the lean diabetic rats revealed complete destruction of pancreatic beta cells and plasma
insulin levels were virtually undetectable. In contrast, the islets of the obese rats revealed insulitis and substantial beta-cell
loss, however autoimmune bete-cell destruction was incomplete, and residual beta cells were presumably responsible for the
presence of measurable levels of plasma insulin and the long-term survival of obese diabetics without insulin therapy. Obese
rats were hyperinsulinaemic, developed diabetes significantly earlier, and with a greater incidence than lean rats, suggesting
a possible relationship between enhanced beta-cell metabolic activity and immune destruction. Obese males became diabetic
more frequently and at an earlier age than obese females and lean rats of both sexes, suggesting a role for gender in the
pathogenesis of diabetes. We conclude that the BBZ/Wor rat is a unique animal model for investigating the interaction of obesity,
beta-cell metabolism, autoimmune insulitis and genetic predisposition to diabetes. 相似文献
34.
35.
36.
Nilana MT Barros Raquel L Neves William N Addison Diego M Assis Monzur Murshed Adriana K Carmona Marc D McKee 《Journal of bone and mineral research》2013,28(3):688-699
X‐linked hypophosphatemia (XLH/HYP)—with renal phosphate wasting, hypophosphatemia, osteomalacia, and tooth abscesses—is caused by mutations in the zinc‐metallopeptidase PHEX gene (phosphate‐regulating gene with homologies to endopeptidase on the X chromosome). PHEX is highly expressed by mineralized tissue cells. Inactivating mutations in PHEX lead to distal renal effects (implying accumulation of a secreted, circulating phosphaturic factor) and accumulation in bone and teeth of mineralization‐inhibiting, acidic serine‐ and aspartate‐rich motif (ASARM)‐containing peptides, which are proteolytically derived from the mineral‐binding matrix proteins of the SIBLING family (small, integrin‐binding ligand N‐linked glycoproteins). Although the latter observation suggests a local, direct matrix effect for PHEX, its physiologically relevant substrate protein(s) have not been identified. Here, we investigated two SIBLING proteins containing the ASARM motif—osteopontin (OPN) and bone sialoprotein (BSP)—as potential substrates for PHEX. Using cleavage assays, gel electrophoresis, and mass spectrometry, we report that OPN is a full‐length protein substrate for PHEX. Degradation of OPN was essentially complete, including hydrolysis of the ASARM motif, resulting in only very small residual fragments. Western blotting of Hyp (the murine homolog of human XLH) mouse bone extracts having no PHEX activity clearly showed accumulation of an ~35 kDa OPN fragment that was not present in wild‐type mouse bone. Immunohistochemistry and immunogold labeling (electron microscopy) for OPN in Hyp bone likewise showed an accumulation of OPN and/or its fragments compared with normal wild‐type bone. Incubation of Hyp mouse bone extracts with PHEX resulted in the complete degradation of these fragments. In conclusion, these results identify full‐length OPN and its fragments as novel, physiologically relevant substrates for PHEX, suggesting that accumulation of mineralization‐inhibiting OPN fragments may contribute to the mineralization defect seen in the osteomalacic bone characteristic of XLH/HYP. © 2013 American Society for Bone and Mineral Research. 相似文献
37.
Gina Shetty BS Georgia M. Beasley MD Sara Sparks BS MT ASCP Michael Barfield MD Melanie Masoud BS Paul J. Mosca MD PhD Scott K. Pruitt MD PhD April K. S. Salama MD Cliburn Chan MD PhD Douglas S. Tyler MD Kent J. Weinhold PhD 《Annals of surgical oncology》2013,20(4):1128-1135
Background
Preprocedure clinical and pathologic factors have failed to consistently differentiate complete response (CR) from progressive disease (PD) in patients after isolated limb infusion (ILI) with melphalan for unresectable in-transit extremity melanoma.Methods
Multiplex immunobead assay technology (Milliplex MAP Human Cytokine/Chemokine Magnetic Bead Panel, Millipore Corp., Billerica, MA; and Magpix analytical test instrument, Luminex Corp., Austin, TX) was performed on pre-ILI plasma to determine concentrations of selected cytokines (MIP-1α, IL-1Rα, IP-10, IL-1β, IL-1α, MCP-1, IL-6, IL-17, EGF, IL-12p40, VEGF, GM-CSF, and MIP-1β) on a subset of patients (n = 180) who experienced CR (n = 23) or PD (n = 24) after ILI. Plasma from normal donors (n = 12) was also evaluated.Results
Of 180 ILIs performed, 28 % (95 % confidence interval 22–35, n = 50) experienced a CR, 14 % (n = 25) experienced a partial response, 11 % (n = 21) had stable disease, 34 % (n = 61) had PD, and 13 % (n = 23) were not evaluable for response. Tumor characteristics and pharmacokinetics appeared similar between CR (n = 23) and PD (n = 24) patients who underwent cytokine analysis. Although there were no differences in cytokine levels between CR and PD patients, there were differences between the melanoma patients and controls. MIP-1α, IL-1Rα, IL-1β, IL-1α, IL-17, EGF, IL-12p40, VEGF, GM-CSF, and MIP-1β were significantly higher in normal controls compared to melanoma patients, while IP-10 was lower (p < 0.001) in controls compared to melanoma patients.Conclusions
Patients with unresectable in-transit melanoma appear to have markedly decreased levels of immune activating cytokines compared to normal healthy controls. This further supports a potential role for immune-targeted therapies and immune monitoring in patients with regionally advanced melanoma. 相似文献38.
A. M. Aiken J. B. Haddow N. R. A. Symons S. Kaptanis A. C. Katz-Summercorn D. Debnath H. Dent S. Tayeh V. Kung S. Clark J. Gahir S. Dindyal S. Farag A. Lazaridis C. P. Bretherton S. Williams A. Currie H. West J. Davies S. Arora A. Kheraj B. M. Stubbs N. Yassin S. Mallappa G. Garrett S. Hislop A. Bhangu Y. Abbey I. Al-Shoek U. Ahmad G. Sharp A. Memarzadeh A. Patel F. Ali H. Kaderbhai C. H. Knowles 《Hernia》2013,17(5):657-664
Purpose
Evidence regarding whether or not antibiotic prophylaxis is beneficial in preventing post-operative surgical site infection in adult inguinal hernia repair is conflicting. A recent Cochrane review based on 17 randomised trials did not reach a conclusion on this subject. This study aimed to describe the current practice and determine whether clinical equipoise is prevalent.Methods
Surgeons in training were recruited to administer the Survey of Hernia Antibiotic Prophylaxis usE survey to consultant-level general surgeons in London and the south-east of England on their practices and beliefs regarding antibiotic prophylaxis in adult elective inguinal hernia repair. Local prophylaxis guidelines for the participating hospital sites were also determined.Results
The study was conducted at 34 different sites and received completed surveys from 229 out of a possible 245 surgeons, a 93 % response rate. Overall, a large majority of hospital guidelines (22/28) and surgeons’ personal beliefs (192/229, 84 %) supported the use of single-dose pre-operative intravenous antibiotic prophylaxis in inguinal hernia repair, although there was considerable variation in the regimens in use. The most widely used regimen was intravenous co-amoxiclav (1.2 g). Less than half of surgeons were adherent to their own hospital antibiotic guidelines for this procedure, although many incorrectly believed that they were following these.Conclusion
In the south-east of England, there is a strong majority of surgical opinion in favour of the use of antibiotic prophylaxis in this procedure. It is therefore likely to be extremely difficult to conduct further randomised studies in the UK to support or refute the effectiveness of prophylaxis in this commonly performed procedure. 相似文献39.
40.